Humus Capital Partners LLC is a private equity firm specializing in middle market, emerging growth, industry consolidation, buyout, and growth capital investments. It seeks to invest in firms specializing in animal protein, frozen foods, and investments in the agribusiness sector in Latin America. The firm prefers to take a seat on the board of directors of its portfolio companies and exit its investments through an IPO or sale to a strategic buyer. It seeks to take a majority stake in its portfolio companies.
Aaktei Management develops renewable energy projects in Chile covering all stages from conceptual idea to construction and COD.
Biosidus
Private Equity Round in 2018
Biosidus S.A is the largest manufacturer and distributor of biosimilar pharmaceuticals. Biosidus SA is an Argentine biotechnology company that in the last three decades has developed a global business in the supply of high-quality biopharmaceuticals in territories of Asia, Africa, Eastern Europe and Latin America. Biosidus SA has two manufacturing plants. The Almagro Plant, located in the Autonomous City of Buenos Aires, is dedicated to R & D activities and the production of pharmaceutical active ingredients, with productive capacity in bacterial fermentation and massive cell culture. The operations of aseptic filling, lyophilization and packing are carried out in the Bernal Plant, located in the outskirts of Buenos Aires. Biosidus has a robust pipeline of therapeutic proteins at different stages of development. The manufacturing processes and new technologies developed by Biosidus are based on a solid intellectual property policy, which constitutes an important competitive advantage in the biosimilars scenario. With its outstanding track record, Biosidus is destined to become a reliable provider of biosimilars worldwide.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.